[
  {
    "ts": "2025-10-09T13:21:10+00:00",
    "headline": "3 Value Stocks with Warning Signs",
    "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
    "url": "https://finance.yahoo.com/news/3-value-stocks-warning-signs-132110419.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a7ccdccf-5d8b-3437-9d34-769010ecfd21",
      "content": {
        "id": "a7ccdccf-5d8b-3437-9d34-769010ecfd21",
        "contentType": "STORY",
        "title": "3 Value Stocks with Warning Signs",
        "description": "",
        "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
        "pubDate": "2025-10-09T13:21:10Z",
        "displayTime": "2025-10-09T13:21:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/931fddf42e72b9823092d1d44623246a",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "POST Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e7QrAH02ynIy_bIQ9_eqMg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/931fddf42e72b9823092d1d44623246a.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jh5OiO4aICs8GP2L2ess2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/931fddf42e72b9823092d1d44623246a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-value-stocks-warning-signs-132110419.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-value-stocks-warning-signs-132110419.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DFIN"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "POST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-09T10:08:30+00:00",
    "headline": "What Do Recent Medicare Negotiation Plans Mean for Bristol-Myers Squibb Shares in 2025?",
    "summary": "Thinking about what to do with Bristol-Myers Squibb stock? You are certainly not alone. With shares closing recently at $44.54, there has been plenty to talk about, especially as the stock has faced some turbulence throughout 2025. Over the last week, Bristol-Myers Squibb slipped by 6.1%, extending a broader trend that has the stock down 4.7% for the month and a striking 21.6% year to date. For those keeping track, the longer-term view has not been much rosier, with returns lagging by 11.5%...",
    "url": "https://finance.yahoo.com/news/recent-medicare-negotiation-plans-mean-100830077.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0939aa1a-7637-373b-a8fb-283f431c7b71",
      "content": {
        "id": "0939aa1a-7637-373b-a8fb-283f431c7b71",
        "contentType": "STORY",
        "title": "What Do Recent Medicare Negotiation Plans Mean for Bristol-Myers Squibb Shares in 2025?",
        "description": "",
        "summary": "Thinking about what to do with Bristol-Myers Squibb stock? You are certainly not alone. With shares closing recently at $44.54, there has been plenty to talk about, especially as the stock has faced some turbulence throughout 2025. Over the last week, Bristol-Myers Squibb slipped by 6.1%, extending a broader trend that has the stock down 4.7% for the month and a striking 21.6% year to date. For those keeping track, the longer-term view has not been much rosier, with returns lagging by 11.5%...",
        "pubDate": "2025-10-09T10:08:30Z",
        "displayTime": "2025-10-09T10:08:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-medicare-negotiation-plans-mean-100830077.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-medicare-negotiation-plans-mean-100830077.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]